Devi Nair, MD
Clinical Cardiac Electrophysiology · Jonesboro, ARNPI 1538357470
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (40.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Boston Scientific at 35.4% of the total. 2025 is the largest year on record at $419,576, 2.8 times the $151,010 reported in 2019. Among clinical cardiac electrophysiology clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 3,050 payments — averaging $575.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$622K
- Abbott$438K
- Medtronic$425K
- Biosense Webster, Inc.$115K
- Siemens Medical Solutions USA, Inc.$50K
- Volta Medical Inc$40K
- plus $66K from 32 others
Across 1,422 payments — averaging $12,334 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$8.6M
- Abbott$6.3M
- Biosense Webster, Inc.$966K
- Medtronic$528K
- Adagio Medical, Inc.$421K
- Recor Medical Inc$414K
- plus $361K from 6 others
Across 1 payment — averaging $97,185 each. An ownership or investment interest held by the physician or an immediate family member.
- Substrate HD$97K
What the payments were for
- Consulting fees$613,19535%
- Speaking & faculty fees$713,88341%
- Grants$3,6950%
- Travel & lodging$337,06719%
- Food & beverage$86,8965%
- Education$1,4100%
- Entertainment$270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$200,730
- AMPLATZER AMULET$117,749
- Watchman$114,651
- Carto 3$88,859
- GENERAL - THERAPIES$85,810
- Farapulse$79,159
- WATCHMAN Access System$78,001
- WATCHMAN FLX$56,698
- Micra$45,759
- AMPLATZER Occluders$42,938
- VX1$39,636
- ACUSON Origin Diagnostic Ultrasound System$33,857
- XARELTO$21,840
- Carto 3 System$17,481
- Arctic Front$16,237
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$11,766
- ENSITE PRECISION$10,531
- ACUSON SC2000 Diagnostic Ultrasound System$9,973
- AFFERA MAPPING SYSTEM$6,903
- GENERAL EP$6,736
How this compares
$1,756,173 in reported general payments places this provider in the 95th percentile of 25 clinical cardiac electrophysiology providers in Arkansas.
See all clinical cardiac electrophysiology providers in Arkansas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 1,468 | $1,019,296 |
| XareltoRivaroxaban | 218 | $160,989 |
| SotalolSotalol Hcl | 1,922 | $24,506 |
| MultaqDronedarone Hcl | 21 | $16,406 |
| Dofetilide | 114 | $14,472 |
| EntrestoSacubitril/Valsartan | 18 | $13,400 |
| JardianceEmpagliflozin | 21 | $12,456 |
| Flecainide Acetate | 256 | $6,873 |
| Amiodarone Hcl | 490 | $4,447 |
| Metoprolol Succinate | 410 | $4,200 |
| Mexiletine Hcl | 61 | $3,285 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 135 | $1,984 |
| Mupirocin | 276 | $1,819 |
| Digoxin | 105 | $1,659 |
| Carvedilol | 288 | $1,607 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $2,888 | $1,019,2961,468 claims |
| Johnson & JohnsonXarelto | $22,850 | $160,989218 claims |
| NovartisEntresto | $101 | $13,40018 claims |
| Boehringer IngelheimJardiance | $17 | $12,45621 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 25 clinical cardiac electrophysiology providers in Arkansas.
Other clinical cardiac electrophysiology in Jonesboro
- Oreoluwa OladiranJonesboro$80K
- Raphael NgengweJonesboro$47K
- David VanceJonesboro$9K
- Monica LoLittle Rock$190K
- Sudarone ThihalolipavanLittle Rock$77K
- Prabhat HebbarLittle Rock$75K
- Bilal SaqiNorth Little Rock$44K
- Gerald GreerLittle Rock$41K
- Risheek KaulLittle Rock$38K
- Yang YangFayetteville$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.